Increased superoxide radical with a decrease in vascular endothelial growth factor and inducible nitric oxide synthase level leads to the progression of left ventricular hypertrophy in a pressure-overload rat heart model

Annals of Thoracic and Cardiovascular Surgery

Volumn 14, Issue 4, 2008, Pages 210-217

  Ji, Kaiqiang ^a   Minakawa, Masahito ^a   Fukui, Kozo ^a   Suzuki, Yasuyuki ^a   Fukuda, Ikuo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Electron spin resonance; Free radical; Hypertrophy; Vascular endothelial growth factor

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NOS2 PROTEIN, RAT; SUPEROXIDE; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL; AORTA; ARTICLE; BLOOD PRESSURE; DISEASE COURSE; DISEASE MODEL; DOWN REGULATION; ELECTRON SPIN RESONANCE; ENZYMOLOGY; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; LIGATION; MALE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; UPREGULATION; WISTAR RAT;

ANIMALS; AORTA; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; HYPERTROPHY, LEFT VENTRICULAR; LIGATION; MALE; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE; SUPEROXIDES; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 54049094836     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992; 256: 628-32.
2. Sohal RS, Brunk UT. Mitochondrial production of pro-oxidants and cellular senescence. Mutat Res 1992; 275: 295-304.
3. Cleeter MW, Cooper JM, Darley Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345: 50-4.
4. Hennet T, Richter C, Peterhans E. Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem J 1993; 289 (Pt 2): 587-92.
5. Hennet T, Bertoni G, Richter C, Peterhans E. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res 1993; 53: 1456-60.
6. Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Radic Biol Med 1988; 5: 409-19.
7. Janssen YM, Van Houten B, Borm PJ, Mossman BT. Cell and tissue responses to oxidative damage. Lab Invest 1993; 69: 261-74.
8. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995; 1271: 67-74.
9. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-8.
10. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, et al. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 1989; 264: 20017-24.
11. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986; 46: 5629-32.
12. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535-45.
13. Sellke FW, Wang SY, Stamler A, Lopez JJ, Li J, et al. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol 1996; 271: H713-20.
14. Ladoux A, Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 1993; 195: 1005-10.
15. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649-52.
16. Minakawa M, Takeuchi K, Ito K, Tsushima T, Fukui K, et al. Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function, but not to glucose metabolism in an early failing heart. Eur J Cardiothorac Surg 2003; 24 : 493-501.
17. Yamakado T, Nakano T. Left ventricular systolic and diastolic function in the hypertrophied ventricle. Jpn Circ J 1990; 54 : 554-62.
18. Josephson RA, Silverman HS, Lakatta EG, Stern MD, Zweier JL. Study of the mechanisms of hydrogen peroxide and hydroxyl free radical-induced cellular injury and calcium overload in cardiac myocytes. J Biol Chem 1991; 266: 2354-61.
19. Siwik DA, Tzortzis JD, Pimental DR, Chang DL, Pagano PJ, et al. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999; 85: 147-53.
20. Sawyer DB, Colucci WS. Mitochondrial oxidative stress in heart failure: "oxygen wastage" revisited. Circ Res 2000; 86: 119-20.
21. McCord JM. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed Proc 1987; 46: 2402-6.
22. Itoh K, Takeuchi K, Minakawa M, et al. Role of oxidative stress in transition of hypertrophied myocardium to heart failure. In: Munakata A ed.; Progress in Transplantation. Amsterdam: Elsevier Science B.V., 2000; pp 33-40.
23. van der Zee R, Murohara T, Luo Z, Zollmann F,Passeri J, et al. Vascular endothelial growth factor/ vascular permeability factor augments nitric oxiderelease from quiescent rabbit and human vascular endothelium. Circulation 1997; 95: 1030-7. (Pubitemid 27091550)
24. Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM, Paulus WJ. Endomyocardial nitric oxide synthaseand left ventricular preload reserve in dilatedcardiomyopathy. Circulation 1999; 99: 3009-16.
25. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF. Myocardial calcium-independent nitricoxide synthase activity is present in dilated cardiomyopathy,myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J 1995; 74: 426-30.
26. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation1996; 93: 1087-94.
27. Drexler H, Kästner S, Strobel A, Studer R, Brodde OE, et al. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol 1998; 32: 955-63.
28. Paulus WJ, Ka¨stner S, Pujadas P, Shah AM, Drexler H, et al. Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft. Circulation 1997; 96: 3436-42.